Oncotarget

Research Papers:

NUSAP1 promotes invasion and metastasis of prostate cancer

Catherine A. Gordon, Xue Gong, Durga Ganesh and James D. Brooks _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:29935-29950. https://doi.org/10.18632/oncotarget.15604

Metrics: PDF 1159 views  |   HTML 1535 views  |   ?  


Abstract

Catherine A. Gordon1, Xue Gong1,2, Durga Ganesh1, James D. Brooks1,3

1Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA

2Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA

3Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA

Correspondence to:

James D. Brooks, email: jdbrooks@stanford.edu

Keywords: NUSAP1, invasion, migration, metastasis, prostate cancer

Received: September 18, 2016    Accepted: January 25, 2017    Published: February 22, 2017

ABSTRACT

We have previously identified nucleolar and spindle associated protein 1 (NUSAP1) as a prognostic biomarker in early stage prostate cancer. To better understand the role of NUSAP1 in prostate cancer progression, we tested the effects of increased and decreased NUSAP1 expression in cell lines, in vivo models, and patient samples. NUSAP1 promotes invasion, migration, and metastasis, possibly by modulating family with sequence similarity 101 member B (FAM101B), a transforming growth factor beta 1 (TGFβ1) signaling effector involved in the epithelial to mesenchymal transition. Our findings provide insights into the importance of NUSAP1 in prostate cancer progression and provide a rationale for further study of NUSAP1 function, regulation, and clinical utility.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15604